why choose us

First received: August 30, 2023

Clinical Trial: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Patients With Generalized Anxiety Disorder (GAD) and Patients With Schizophrenia (SCZ)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Volunteers Generalized Anxiety Disorder (GAD) Schizophrenia (SCZ)

Study Type: INTERVENTIONAL


Official Title: A Multiple Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Patients With Generalized Anxiety Disorder (GAD) and Patients With Sc

Brief Summary: The purpose of this study is to assess the pharmacokinetics, safety, and tolerability following multiple ascending oral doses of ABBV-932 or placebo in healthy adult participants and patients with Generalized Anxiety Disorder (GAD) and patients with schizophrenia (SCZ).

Read more